美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
68462-721-01	68462-721	HUMAN PRESCRIPTION DRUG	Theophylline	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20210603	N/A	ANDA	ANDA212184	Glenmark Pharmaceuticals Inc., USA	THEOPHYLLINE ANHYDROUS	300 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-721-01)
68462-721-05	68462-721	HUMAN PRESCRIPTION DRUG	Theophylline	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20210603	N/A	ANDA	ANDA212184	Glenmark Pharmaceuticals Inc., USA	THEOPHYLLINE ANHYDROUS	300 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-721-05)
68462-721-10	68462-721	HUMAN PRESCRIPTION DRUG	Theophylline	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20210603	N/A	ANDA	ANDA212184	Glenmark Pharmaceuticals Inc., USA	THEOPHYLLINE ANHYDROUS	300 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-721-10)
68462-721-30	68462-721	HUMAN PRESCRIPTION DRUG	Theophylline	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20210603	N/A	ANDA	ANDA212184	Glenmark Pharmaceuticals Inc., USA	THEOPHYLLINE ANHYDROUS	300 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-721-30)
68462-722-01	68462-722	HUMAN PRESCRIPTION DRUG	Theophylline	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20210603	N/A	ANDA	ANDA212184	Glenmark Pharmaceuticals Inc., USA	THEOPHYLLINE ANHYDROUS	450 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-722-01)
68462-722-05	68462-722	HUMAN PRESCRIPTION DRUG	Theophylline	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20210603	N/A	ANDA	ANDA212184	Glenmark Pharmaceuticals Inc., USA	THEOPHYLLINE ANHYDROUS	450 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-722-05)
68462-722-30	68462-722	HUMAN PRESCRIPTION DRUG	Theophylline	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20210603	N/A	ANDA	ANDA212184	Glenmark Pharmaceuticals Inc., USA	THEOPHYLLINE ANHYDROUS	450 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-722-30)